Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Gynecol Oncol. 2010 Jan 19;116(3):516. doi: 10.1016/j.ygyno.2009.11.021

Table 2.

Early onset endometrial cancer (Group 1): immunohistochemistry and MSI testing results (n=50)

Total MSI-H MSI-L MSS Unknown
Absent MLH1 6 (12%) 5 1 0 0
Absent MSH2 1 (2%) 1 0 0 0
Total absent
IHC
7 (14%)
Weak MLH1 9 (18%) 1 2 5 1
Weak MSH6 3 (6%) 2 0 1 0
Total weak IHC 12 (24%)
Normal IHC 31 (62%)

MSI = microsatellite instability; MSI-H = MSI-high; MSI-L = MSI-low; MSS = microsatellite stable; IHC = immunohistochemistry